Trophogen, Inc

Trophogen, Inc. is a biotechnology company founded in 2001 with series A funding from Toucan Capital, focusing on the development of high affinity glycoprotein hormone and related growth factor analogs for targeted therapy and imaging of ovarian, breast, prostate, testicular and thyroid cancers as well as for human and animal infertility.

Contact Details: 6 Taft Court, Suite 150 Rockville Maryland 20850 United States of America Tel: (301) 838-1935 Fax: (301) 762-6287 Email: kdugard@trophogen.com WWW: www.trophogen.com/

Loading...

BioNews Results for Trophogen, Inc:
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	Montana's News Station:  Aug 31 2008 2:04PM Matching: inc
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	KSLA:  Aug 30 2008 3:44PM Matching: inc
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	KRON4:  Aug 30 2008 11:18AM Matching: inc
Biotechs Ahead of Pharma in '08 New Drug Approvals	Macro World Investor:  Aug 29 2008 11:23PM Matching: inc
Biotechs Ahead of Pharma in '08 New Drug Approvals	Calibre Macro World:  Aug 29 2008 10:55PM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Trophogen, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 197 times since April 2007, the link to the organisation's website has been followed 43 times

Recent Search Terms used to find this page: 762-6287 | f | trophogen com | Trophogen | .

Search for more companies in Rockville

Search for more companies in Maryland

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Trophogen, Inc